Stock Events

Stock Events

Akero Therapeutics (AKRO) Q2 2025 Earnings

12MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-1.16

-1.04

-0.93

-0.81

Details

Expected EPS

-0.959243

Actual EPS

-0.9

Surprise EPS

0.06

Surprise Percent

+6.18%

Description

Akero Therapeutics (AKRO) has reported earnings of -0.9 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.